Bibliography

Found 74 results
Filters: Author is Gelman, Benjamin  [Clear All Filters]
Journal Article
Grant I, Franklin D, Deutsch R, Woods SPaul, Vaida F, Ellis RJ, Letendre S, Marcotte TD, Atkinson JH, Collier AC, et al. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014 ;82(23):2055-62.
Gelman B, Schuenke KW. Brain aging in acquired immunodeficiency syndrome: increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation. Journal of NeuroVirology [Internet]. 2004 ;10(2):98-108. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15204928
Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, Collier AC, Gelman B, McArthur J, Morgello S, et al. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011 ;25(14):1747-51.
Soontornniyomkij V, Moore D, Gouaux B, Soontornniyomkij B, Tatro ET, Umlauf A, Masliah E, Levine AJ, Singer EJ, Vinters HV, et al. Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers. AIDS [Internet]. 2012 ;26(18):2327-2335. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23018443
Perez-Valero I, Ellis RJ, Heaton RK, Deutsch R, Franklin D, Clifford DB, Collier AC, Gelman B, Marra C, McCutchan JA, et al. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects. AIDS. 2019 ;33(3):475-481.
Bharti AR, Letendre SL, Wolfson T, Clifford D, Collier AC, Gelman B, McArthur J, Marra C, McCutchan A, Morgello S, et al. Clinical variables identify seronegative HCV co-infection in HIV-infected individuals. J Clin Virol. 2011 ;52(4):328-32.
Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, Moore D, Ellis RJ, Cherner M, Gelman B, et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. Journal of Neurovirology [Internet]. 2009 ;15:360-70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20175693
Sakamoto M, Marcotte TD, Umlauf A, Franklin D, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, et al. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 ;62(1):36-42.
Livelli A, Vaida F, Ellis RJ, Ma Q, Ferrara M, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, et al. Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study. Lancet HIV. 2019 ;6(7):e456-e462.
Mukerjee R, Chang JR, Del-Valle L, Bagashev A, Gayed MM, Lyde RB, Hawkins BJ, Brailoiu E, Cohen E, Power C, et al. Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. J Biol Chem [Internet]. 2011 ;286:34976-85. Available from: http://www.ncbi.nlm.nih.gov/pubmed?term=21816823
Saloner R, Heaton RK, Campbell LM, Chen A, Franklin D, Ellis RJ, Collier AC, Marra C, Clifford DB, Gelman B, et al. Effects of comorbidity burden and age on brain integrity in HIV. AIDS. 2019 ;33(7):1175-1185.
Lin K, Taylor MJ, Heaton R, Franklin D, Jernigan T, Fennema-Notestine C, McCutchan A, J Atkinson H, Ellis RJ, McArthur J, et al. Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals. J Clin Exp Neuropsychol. 2011 ;33(3):326-34.
Shah M, Smit TK, Morgello S, Tourtellotte W, Gelman B, Brew BJ, Saksena NK. Env gp120 sequence analysis of HIV type 1 strains from diverse areas of the brain shows preponderance of CCR5 usage. AIDS Research and Human Retroviruses [Internet]. 2006 ;22:177-81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16478400
Watson CWei-Ming, Kamalyan L, Tang B, Hussain MA, Cherner M, Mindt MRivera, Byrd DA, Franklin DR, Collier AC, Clifford DB, et al. Ethnic/Racial Disparities in Longitudinal Neurocognitive Decline in People With HIV. J Acquir Immune Defic Syndr. 2022 ;90(1):97-105.
Nguyen A, Rossi S, Croteau D, Best BM, Clifford DB, Collier AC, Gelman B, Marra C, McArthur JC, McCutchan JA, et al. Etravirine in CSF is highly protein bound. J Antimicrob Chemother. 2013 ;68(5):1161-8.
Obermeit LC, Beltran J, Casaletto KB, Franklin DR, Letendre S, Ellis R, Fennema-Notestine C, Vaida F, Collier AC, Marra CM, et al. Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND. J Neurovirol. 2017 ;23(1):67-78.
Kallianpur AR, Hulgan T, Wen W, Canter JA, Haas DW, Gelman B. Hemochromatosis (HFE) Gene Polymorphisms and HIV-Associated Brain Pathology at Autopsy: Results of a NeuroAIDS DNA Bank Study. Jounral of Neurovirology. 2009 .
Diaz-Arrastia R, Gong Y, Kelly CJ, Gelman B. Host genetic polymorphisms in human immunodeficiency virus-related neurologic disease. Journal of NeuroVirology [Internet]. 2004 ;10 Suppl 1:67-73. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14982742
Schuenke KW, Gelman B. Human microglial cell isolation from adult autopsy brain: brain pH, regional variation, and infection with human immunodeficiency virus type 1. Journal of NeuroVirology [Internet]. 2003 ;9(3):346-57. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12775418
Fennema-Notestine C, Ellis RJ, Archibald SL, Jernigan TL, Letendre S, Notestine RJ, Taylor MJ, Theilmann RJ, Julaton MD, Croteau D, et al. Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neurovirol. 2013 ;19(4):393-401.
Smit TK, Brew BJ, Tourtellotte W, Morgello S, Gelman B, Saksena NK. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. Journal of Virology [Internet]. 2004 ;78(18):10133-48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15331746
Woods SPaul, Rippeth JD, Frol AB, Levy JK, Ryan EL, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. Journal of Clinical and Experimental Neuropsychology [Internet]. 2004 ;26(6):759-78. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15370374
Morgello S, Holzer CE, Ryan EL, Young C, Naseer M, Castellon SA, Frol AB, Atkinson JH, Gelman B, Grant I, et al. Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium. International Journal of Methods in Psychiatric Research [Internet]. 2006 ;15:131-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17019897
Levine AJ, Soontornniyomkij V, Achim C, Masliah E, Gelman B, Sinsheimer JS, Singer EJ, Moore D. Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV. Journal of NeuroVirology. Journal of Neurovirology. 2015 .
Morgello S, Gelman B, Kozlowski PB, Vinters HV, Masliah E, Cornford M, Cavert W, Marra CM, Grant I, Singer EJ. The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathology and Applied Neurobiology [Internet]. 2001 ;27(4):326-35. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11532163

Pages